Order Article Reprints

Badarni M, Prasad M, Golden A, Bhattacharya B, Levin L, Yegodayev KM, Dimitstein O, Joshua B-Z, Cohen L, Khrameeva E, et al. IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck Cancer. Cancers. 2021; 13(9):2250. https://doi.org/10.3390/cancers13092250

Badarni, Mai, Manu Prasad, Artemiy Golden, Baisali Bhattacharya, Liron Levin, Ksenia M. Yegodayev, Orr Dimitstein, Ben-Zion Joshua, Limor Cohen, Ekaterina Khrameeva, and et al. 2021. "IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck Cancer" Cancers 13, no. 9: 2250. https://doi.org/10.3390/cancers13092250

Badarni, M., Prasad, M., Golden, A., Bhattacharya, B., Levin, L., Yegodayev, K. M., Dimitstein, O., Joshua, B.-Z., Cohen, L., Khrameeva, E., Kong, D., Porgador, A., Braiman, A., Grandis, J. R., Rotblat, B., & Elkabets, M. (2021). IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck Cancer. Cancers, 13(9), 2250. https://doi.org/10.3390/cancers13092250